To assess the prognostic significance of ATP2B4 (PMCA4) expression in the clinical outcome of HR+ breast carcinoma subtypes, the publicly available KM Plotter online tool30 (www.kmplot.com) was used. This evidence concerns the gene ATP2B4 and breast carcinoma.